An autologous tumor-derived heat shock protein vaccine for high risk ovarian cancer

被引：0
|
作者：
Li, Z [1 ]
Nash, JD [1 ]
Qiao, Y [1 ]
Kulko, JM [1 ]
Wilcox, DK [1 ]
Gaffney, J [1 ]
Runowicz, CD [1 ]
Simonich, SA [1 ]
Liu, B [1 ]
Srivastava, PK [1 ]
机构：
[1] Univ Connecticut, Sch Med, Farmington, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：859S / 859S
页数：1
相关论文
共 50 条
  • [31] A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
    Sanborn, Rachel E.
    Ross, Helen J.
    Aung, Sandra
    Acheson, Anupama
    Moudgil, Tarsem
    Puri, Sachin
    Hilton, Traci
    Fisher, Brenda
    Coffey, Todd
    Paustian, Christopher
    Neuberger, Michael
    Walker, Edwin
    Hu, Hong-Ming
    Urba, Walter J.
    Fox, Bernard A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [32] Therapeutic efficacy of tumor-derived heat shock protein 70 immunoth erapy combining interleukin-2 on tumor-bearing mice
    傅庆国
    孟凡东
    沈晓东
    郭仁宣
    ChineseMedicalJournal, 2003, (02)
  • [33] Therapeutic antitumor efficacy of tumor-derived autophagosome (DRibble) vaccine on head and neck cancer
    Su, Hang
    Luo, Qiong
    Xie, Hao
    Huang, Xiaofeng
    Ni, Yanhong
    Mou, Yongbin
    Hu, Qingang
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 1921 - 1930
  • [34] The Expression of Tumor-Derived and Stromal-Derived Matrix Metalloproteinase 2 Predicted Prognosis of Ovarian Cancer
    Fu, Ziyi
    Xu, Sujuan
    Xu, Ye
    Ma, Jiehua
    Li, Jingyun
    Xu, Pengfei
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (03) : 356 - 362
  • [35] Characterization of ascites and tumor-derived ovarian cancer stem-like cells.
    Kaipio, Katja
    Chen, Ping
    Huhtinen, Kaisa
    Mikkonen, Piia
    Ostling, Paivi
    Mpindi, John Patrick
    Lehtinen, Laura
    Roering, Pia
    Korpela, Taina
    Wennerberg, Krister
    Yadav, Bhagwan
    Aittokallio, Tero
    Kulesskiy, Evgeny
    Hynninen, Johanna
    Auranen, Annika
    Grenman, Seija
    Hautaniemi, Sampsa
    Carpen, Olli
    CLINICAL CANCER RESEARCH, 2016, 22
  • [36] Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity
    Ueda, G
    Tamura, Y
    Hirai, I
    Kamiguchi, K
    Ichimiya, S
    Torigoe, T
    Hiratsuka, H
    Sunakawa, H
    Sato, N
    CANCER SCIENCE, 2004, 95 (03): : 248 - 253
  • [37] Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings (vol 20, pg 4169, 2002)
    Srivastava, P
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) : 4610 - 4610
  • [38] Autologous ovarian tumor cells vaccine, modified with the hapten, dinitrophenyl (DNP), in platinum resistant ovarian cancer
    Taha, M.
    Berd, D.
    Williams, S.
    Del Priore, G.
    Standiford, S.
    Brown, K.
    Pollock, T.
    Jaggernauth, S.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 428 - 428
  • [39] Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100-21 study group
    Testori, Alessandro
    Richards, Jon
    Whitman, Eric
    Mann, G. Bruce
    Lutzky, Jose
    Camacho, Luis
    Parmiani, Giorgio
    Tosti, Giulio
    Kirkwood, John M.
    Hoos, Axel
    Yuh, Lianng
    Gupta, Renu
    Srivastava, Pramod K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 955 - 962
  • [40] Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96
    Janetzki, S
    Blachere, NE
    Srivastava, PK
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (04): : 269 - 276
12345